STAT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.198000E-01
Normal-vs-Stage2
2.863200E-01
Normal-vs-Stage3
1.438600E-01
Normal-vs-Stage4
1.211230E-01
Stage1-vs-Stage2
3.040100E-02
Stage1-vs-Stage3
9.134200E-01
Stage1-vs-Stage4
6.260000E-01
Stage2-vs-Stage3
3.541800E-01
Stage2-vs-Stage4
6.196200E-01
Stage3-vs-Stage4
7.680200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.750000E-01
Normal-vs-AfricanAmerican
2.169600E-01
Normal-vs-Asian
7.094000E-02
Caucasian-vs-AfricanAmerican
3.371000E-01
Caucasian-vs-Asian
9.816600E-01
AfricanAmerican-vs-Asian
4.847600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.769000E-01
Normal-vs-Female
2.682200E-01
Male-vs-Female
7.540400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.431000E-01
Normal-vs-Age(41-60Yrs)
3.096800E-01
Normal-vs-Age(61-80Yrs)
2.574200E-01
Normal-vs-Age(81-100Yrs)
4.236300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.136400E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.655600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.071200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.598500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.113800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.984400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.162200E-01
Normal-vs-Daily Drinker
2.481600E-01
Normal-vs-Weekly Drinker
8.825700E-02
Normal-vs-Occasional Drinker
2.750600E-01
Normal-vs-Social Drinker
6.171700E-02
Non Drinker-vs-Daily Drinker
4.038200E-01
Non Drinker-vs-Weekly Drinker
4.111600E-02
Non Drinker-vs-Occasional Drinker
1.865600E-01
Non Drinker-vs-Social Drinker
2.623900E-02
Daily Drinker-vs-Weekly Drinker
1.636000E-01
Daily Drinker-vs-Occasional Drinker
5.838600E-01
Daily Drinker-vs-Social Drinker
1.223620E-01
Weekly Drinker-vs-Occasional Drinker
3.678600E-01
Weekly Drinker-vs-Social Drinker
9.822600E-01
Occasional Drinker-vs-Social Drinker
3.108200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.509600E-01
Normal-vs-Grade 2
1.832620E-01
Normal-vs-Grade 3
1.485170E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.881900E-03
Grade 1-vs-Grade 3
1.379620E-03
Grade 1-vs-Grade 4
8.509600E-01
Grade 2-vs-Grade 3
3.514200E-01
Grade 2-vs-Grade 4
1.832620E-01
Grade 3-vs-Grade 4
1.485170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.561200E-01
Normal-vs-NonDiabetic
2.700600E-01
Diabetic-vs-NonDiabetic
6.334000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.875800E-01
Normal-vs-NoPancreatitis
2.641200E-01
Pancreatitis-vs-NoPancreatitis
7.332400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.481200E-01
Normal-vs-N1
2.844800E-01
N0-vs-N1
2.125800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.586800E-01
Normal-vs-TP53-NonMutant
8.801200E-03
TP53-Mutant-vs-TP53-NonMutant
2.562800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
